Squarepoint’s Bio Green Med Solution Inc BGMS Stock Holding History

Squarepoint’s Portfolio BGMS Stock Details BGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7	Closed	-$169K	–	3325
2021 Q1	$169K	Buy	+7	New	+$197K	﹤0.01%	2763

Other funds holding BGMS

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TLP

Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Squarepoint's BGMS Position: Q2 2021 in Review

Squarepoint sold out of Bio Green Med Solution Inc (BGMS) in Q2 2021, closing a stake of 7 shares — an estimated $169K sold.

Squarepoint first reported a position in BGMS in Q1 2021 and held it in 1 quarter. The position peaked at $169K in Q1 2021. 25 funds tracked by Wall St. Rank hold BGMS as of Q2 2021.

Squarepoint reported no remaining Bio Green Med Solution Inc position as of Q2 2021 after selling out during the quarter.
Squarepoint sold 7 Bio Green Med Solution Inc shares in Q2 2021, an estimated $169K.
Squarepoint first reported a position in Bio Green Med Solution Inc in Q1 2021 and held it in 1 quarter.
Squarepoint's Bio Green Med Solution Inc position peaked at $169K in Q1 2021.
25 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.